Trinity Historical Cash Flow
| TRIB Stock | USD 1.10 0.02 1.79% |
Analysis of Trinity Biotech cash flow over time is an excellent tool to project Trinity Biotech plc future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as End Period Cash Flow of 3.5 M or Sale Purchase Of Stock of 0.0 as it is a great indicator of Trinity Biotech ability to facilitate future growth, repay debt on time or pay out dividends.
Financial Statement Analysis is much more than just reviewing and examining Trinity Biotech plc latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Trinity Biotech plc is a good buy for the upcoming year.
Trinity |
About Trinity Cash Flow Analysis
The Cash Flow Statement is a financial statement that shows how changes in Trinity balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which Trinity's non-liquid assets can be easily converted into cash.
Trinity Biotech Cash Flow Chart
Add Fundamental
Change To Inventory
The increase or decrease in the amount of inventory a company has over a certain period.Change In Working Capital
The difference in the amount of working capital from one period to the next, indicating the change in a company's short-term assets and liabilities.Begin Period Cash Flow
The amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities.Depreciation
Depreciation indicates how much of Trinity Biotech plc value has been used up. For tax purposes Trinity Biotech can deduct the cost of the tangible assets it purchases as business expenses. However, Trinity Biotech plc must depreciate these assets in accordance with IRS rules about how and when the deduction may be taken, and how long it will last. The systematic allocation of the cost of a tangible asset over its useful life.Most accounts from Trinity Biotech's cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into Trinity Biotech plc current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Trinity Biotech plc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. At present, Trinity Biotech's Other Non Cash Items is projected to increase significantly based on the last few years of reporting. The current year's Change To Account Receivables is expected to grow to about 1.1 M, whereas Change To Inventory is forecasted to decline to (1 M).
Trinity Biotech cash flow statement Correlations
Click cells to compare fundamentals
Trinity Biotech Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Trinity Biotech cash flow statement Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Change To Inventory | (3.0M) | (3.4M) | (4.4M) | (877K) | (971K) | (1.0M) | |
| Change In Cash | (13.9M) | 10.9M | (1.4M) | (19.3M) | (2.9M) | (2.7M) | |
| Free Cash Flow | (9.9M) | 13.6M | 4.5M | (6.9M) | (14.3M) | (13.5M) | |
| Change In Working Capital | (796K) | 4.1M | (172K) | (1.7M) | (2.7M) | (2.8M) | |
| Begin Period Cash Flow | 30.3M | 16.4M | 27.3M | 25.9M | 6.6M | 6.2M | |
| Other Cashflows From Financing Activities | (463K) | 524K | (3.1M) | 14.7M | (8.7M) | (8.2M) | |
| Depreciation | 4.9M | 3.1M | 2.7M | 2.3M | 1.8M | 1.7M | |
| Other Non Cash Items | (10.6M) | 22.3M | 8.9M | 37.9M | 11.4M | 11.9M | |
| Capital Expenditures | 15.4M | 10.2M | 8.7M | 6.0M | 803K | 762.9K | |
| Total Cash From Operating Activities | 5.5M | 23.8M | 13.2M | (921K) | (11.6M) | (11.0M) | |
| Net Income | 12.2M | (6.4M) | 875K | (41.0M) | (24.0M) | (22.8M) | |
| Total Cash From Financing Activities | (4.0M) | (2.7M) | (6.0M) | (12.3M) | (16.0M) | (15.2M) | |
| End Period Cash Flow | 16.4M | 27.3M | 25.9M | 6.6M | 3.7M | 3.5M | |
| Change To Account Receivables | 445K | (2.5M) | 6.2M | (966K) | 1.0M | 1.1M | |
| Stock Based Compensation | 758K | 792K | 1.1M | 1.8M | 2.1M | 1.4M | |
| Total Cashflows From Investing Activities | (17.4M) | (11.9M) | (10.2M) | (7.1M) | (6.4M) | (6.7M) | |
| Net Borrowings | (11.9M) | (3.5M) | 1.3M | (1.1M) | (969.3K) | (920.8K) | |
| Change To Netincome | 31.0M | 30.4M | 27.4M | 12.8M | 14.7M | 14.0M | |
| Change To Liabilities | (3.4M) | 151K | 5.0M | (7.6M) | (6.8M) | (6.5M) | |
| Investments | (11.9M) | (10.2M) | (8.7M) | (6.0M) | 24.8M | 26.0M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Trinity Biotech plc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Trinity Biotech's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Trinity Biotech Plc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Trinity Biotech Plc Stock:Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Trinity Biotech plc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Trinity Biotech. If investors know Trinity will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Trinity Biotech listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.77) | Earnings Share (2.25) | Revenue Per Share 6.968 | Quarterly Revenue Growth 0.14 | Return On Assets (0.1) |
The market value of Trinity Biotech plc is measured differently than its book value, which is the value of Trinity that is recorded on the company's balance sheet. Investors also form their own opinion of Trinity Biotech's value that differs from its market value or its book value, called intrinsic value, which is Trinity Biotech's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Trinity Biotech's market value can be influenced by many factors that don't directly affect Trinity Biotech's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Trinity Biotech's value and its price as these two are different measures arrived at by different means. Investors typically determine if Trinity Biotech is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Trinity Biotech's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.